地中海灌木物种作为抗神经退行性疾病的生物分子来源
Natividad Chaves1, Laura Nogales1, Ismael Montero-Fernández1
1Department of Plant Biology, Ecology and Earth Sciences, Faculty of Science, Universidad de Extremadura, 06080 Badajoz, Spain.
Molecules (Basel, Switzerland)
|December 23, 2023
概括
富含化合物的地中海植物提供天然的神经保护,防止与神经退行性疾病相关的氧化应激. 这些植物衍生化合物有望成为当前治疗方法的更安全替代品.
科学领域:
- 药理学和生物技术的发展
- 自然产品化学 自然产品化学
- 神经科学是一个神经科学.
背景情况:
- 神经退行性疾病与细胞氧化应激有关,这是氧化-减氧反应的不平衡.
- 目前针对这些疾病的治疗方法往往是无效的,并且伴有不良影响.
- 自然产品,特别是来自植物的化合物,表现出抗氧化和自由基中和性质,表明治疗潜力.
研究的目的:
- 确定和评估地中海植物物种作为神经保护生物分子的来源.
- 为了研究典型的地中海植物中的化合物含量,以潜在的治疗应用.
- 探索用于管理与氧化应激相关的神经退行性疾病的自然替代方案.
主要方法:
- 选择了24种地中海代表的植物物种.
- 鉴定和分析化合物,重点是酸和黄.
- 文献审查,以将已识别的化合物与神经保护性质相关联.
主要成果:
- 在24种植物物种中,共发现了403种化合物.
- 酸占确定的化合物的35.7%和黄类55.6%.
- 酸,氨酸和氨酸等关键化合物广泛分布,与神经保护有关. *Pistacia lentiscus*, *Lavandula stoechas* 和 *Thymus vulgaris* 是因为它们丰富的性成分而被强调的.
结论:
- 地中海植物物种是具有神经保护潜力的化合物的重要来源.
- 这些天然化合物可以作为神经退行性疾病的有价值的替代品或补充疗法.
- 鉴定出的植物性化合物对制药和生物技术行业在开发新型治疗中具有前景.
相关概念视频
01:40Overview of Metabolism
30.3K
Living cells constantly carry out various chemical reactions which are necessary for their proper functioning. These reactions are interlinked to one another via multiple pathways. The collection of these chemical reactions is known as metabolism.
Plant Metabolism
Sunlight, the primary source of energy in plants, is first absorbed by the chlorophyll pigments present in their leaves. Plants then use this energy to carry out photosynthesis, where water is oxidized into oxygen and carbon dioxide...
Plant Metabolism
Sunlight, the primary source of energy in plants, is first absorbed by the chlorophyll pigments present in their leaves. Plants then use this energy to carry out photosynthesis, where water is oxidized into oxygen and carbon dioxide...
30.3K
01:26Alzheimer's Disease: Overview
492
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
492
01:22Alzheimer's Disease: Treatment
195
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
195
01:29Drugs Affecting Neurotransmitter Synthesis
1.4K
Drugs affecting neurotransmitter synthesis can impact the adrenergic neuron and the synthesis of neurotransmitters. For example, α-methyltyrosine and carbidopa target specific enzymes involved in catecholamine synthesis. α-methyltyrosine inhibits the enzyme tyrosine hydroxylase, which converts tyrosine into dopamine. By blocking this enzyme, α-methyltyrosine reduces dopamine production and other catecholamines. Carbidopa, on the other hand, inhibits the enzyme dopa decarboxylase,...
1.4K
01:30Cognitive Enhancers: Cholinesterase Inhibitors and NMDA Receptor Antagonists
128
Cognitive enhancers, also known as "smart drugs," are substances used to enhance memory, mental alertness, and concentration. These can be natural or synthetic and improve cognition in conditions like Alzheimer's disease (AD) and other neurodegenerative diseases. Some common examples include caffeine, amphetamines, methylphenidate, modafinil, arecoline, donepezil, vortioxetine, and piracetam. These enhancers work on the principle of synaptic plasticity and altered circuit function.
128
01:15Parkinson's Disease: Overview
554
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
554